Literature DB >> 23507656

Impact of conversion from pegylated interferon-α2b to interferon-α2a for treating recurrent hepatitis C after liver transplantation.

Toru Ikegami, Ken Shirabe, Tomoharu Yoshizumi, Norihiro Furusyo, Kazuhiro Kotoh, Masaki Kato, Shinji Shimoda, Yuji Soejima, Takashi Motomura, Takasuke Fukuhara, Yoshihiko Maehara.   

Abstract

Mesh:

Substances:

Year:  2013        PMID: 23507656     DOI: 10.1097/TP.0b013e318283a82e

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  2 in total

1.  Strategies to treat interferon-induced graft dysfunction after living donor liver transplantation for hepatitis C.

Authors:  Toru Ikegami; Huanlin Wang; Tomoharu Yoshizumi; Takeo Toshima; Shinichi Aishima; Takasuke Fukuhara; Norihiro Furusyo; Kazuhiro Kotoh; Shinji Shimoda; Ken Shirabe; Yoshihiko Maehara
Journal:  Hepatol Int       Date:  2013-12-27       Impact factor: 6.047

Review 2.  Management of hepatitis C infection before and after liver transplantation.

Authors:  Stefano Fagiuoli; Roberto Ravasio; Maria Grazia Lucà; Anna Baldan; Silvia Pecere; Alessandro Vitale; Luisa Pasulo
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.